Cargando…

Gleaning after the European Headache Federation consensus statement on refractory chronic migraine

Detalles Bibliográficos
Autores principales:	Martelletti, Paolo, Lampl, Christian, Russell, Michael-Bjorn, Mitsikostas, Dimos-Dimitrios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer 2014
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4256965/ https://www.ncbi.nlm.nih.gov/pubmed/25394545 http://dx.doi.org/10.1186/1129-2377-15-75

Ejemplares similares

Refractory chronic migraine: a Consensus Statement on clinical definition from the European Headache Federation
por: Martelletti, Paolo, et al.
Publicado: (2014)

Refractory Headache: One Term does Not cover All – A Statement of the European Headache Federation
por: Lampl, Christian, et al.
Publicado: (2014)

Refractory chronic cluster headache: a consensus statement on clinical definition from the European Headache Federation
por: Mitsikostas, Dimos D, et al.
Publicado: (2014)

Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation
por: Bendtsen, Lars, et al.
Publicado: (2018)

European headache federation consensus on the definition of resistant and refractory migraine: Developed with the endorsement of the European Migraine & Headache Alliance (EMHA)
por: Sacco, Simona, et al.
Publicado: (2020)

Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)
por: Sacco, Simona, et al.
Publicado: (2017)

Correction to: Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)
por: Sacco, Simona, et al.
Publicado: (2018)

European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
por: Sacco, Simona, et al.
Publicado: (2019)

Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age: a consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH)
por: Sacco, Simona, et al.
Publicado: (2018)

Correction to: European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
por: Sacco, Simona, et al.
Publicado: (2019)

Comment on: Martelletti et al. Refractory chronic migraine: a consensus statement on clinical definition from the European Headache Federation
por: Wöber, Christian, et al.
Publicado: (2014)

European headache federation consensus on technical investigation for primary headache disorders
por: Mitsikostas, D. D., et al.
Publicado: (2016)

Framing education on headache disorders into the Global Burden of Disease Study 2010. The European Headache Federation stands ready
por: Martelletti, Paolo, et al.
Publicado: (2013)

Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance
por: Sacco, Simona, et al.
Publicado: (2021)

Cluster headache: a quasi-rare disorder needing a reappraisal
por: Martelletti, Paolo, et al.
Publicado: (2015)

Consensus of the Hellenic Headache Society on the diagnosis and treatment of migraine
por: Kouremenos, Evangelos, et al.
Publicado: (2019)

European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure
por: Sacco, Simona, et al.
Publicado: (2022)

Neuromodulation of chronic headaches: position statement from the European Headache Federation
por: Martelletti, Paolo, et al.
Publicado: (2013)

European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update
por: Sacco, Simona, et al.
Publicado: (2022)

Treating primary headaches – management of migraine
por: Mitsikostas, Dimos D
Publicado: (2013)

Are indirect comparisons for treatments in migraine necessitas? Many inevitable challenges to overcome
por: Deligianni, Christina, et al.
Publicado: (2023)

Première of a partnership: European Headache Federation and The Journal of Headache and Pain
por: Martelletti, P., et al.
Publicado: (2006)

Latest clinical recommendations on valproate use for migraine prophylaxis in women of childbearing age: overview from European Medicines Agency and European Headache Federation
por: Vatzaki, Efstratia, et al.
Publicado: (2018)

European Headache Federation recommendations for placebo and nocebo terminology
por: Mitsikostas, Dimos D., et al.
Publicado: (2020)

The Polish Headache Society and the Headache Section of the Polish Neurological Society Consensus Statement: update on new pharmacological therapies for migraine in clinical practice and public medication reimbursement program for chronic migraine
por: Domitrz, Izabela, et al.
Publicado: (2022)

The Journal of Headache and Pain keeps gaining consensus
por: Martelletti, Paolo
Publicado: (2010)

Letter to the editor regarding European Headache Federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
por: Nichols, Russell, et al.
Publicado: (2019)

European Headache Federation guideline on idiopathic intracranial hypertension
por: Hoffmann, Jan, et al.
Publicado: (2018)

Neck pain in episodic migraine: premonitory symptom or part of the attack?
por: Lampl, Christian, et al.
Publicado: (2015)

Chronic migraine plus medication overuse headache: two entities or not?
por: Negro, Andrea, et al.
Publicado: (2011)

Letter to the editor: European headache federation guidelines on the use of monoclonal antibodies acting on the calcitonin gene-related peptide or its receptor for migraine prevention
por: Mikol, Daniel D., et al.
Publicado: (2019)

Guidelines for the organization of headache education in Europe: the headache school II
por: Jensen, Rigmor, et al.
Publicado: (2010)

European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention – part 3: topiramate
por: Raffaelli, Bianca, et al.
Publicado: (2023)

The journey from genetic predisposition to medication overuse headache to its acquisition as sequela of chronic migraine
por: Martelletti, Paolo
Publicado: (2018)

New players in the preventive treatment of migraine
por: Mitsikostas, Dimos D., et al.
Publicado: (2015)

European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention—part 2: flunarizine
por: Deligianni, Christina I., et al.
Publicado: (2023)

Headaches in the emergency department –a survey of patients’ characteristics, facts and needs
por: Doretti, Alberto, et al.
Publicado: (2019)

Does the Intensity of the Headache Differ According to the Level of Neck Disability in Chronic Migraine Patients?
por: Onan, Dilara, et al.
Publicado: (2022)

European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention—part 1: amitriptyline
por: Lampl, Christian, et al.
Publicado: (2023)

The Role of Galcanezumab in Migraine Prevention: Existing Data and Future Directions
por: Gklinos, Panagiotis, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dfkpct9higb65av27bm7ge80cb